BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 1312168)

  • 1. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
    Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
    van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
    Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
    Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
    J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2003 Mar; 54(1):99-108. PubMed ID: 12674222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level.
    Droste SK; Chandramohan Y; Hill LE; Linthorst AC; Reul JM
    Neuroendocrinology; 2007; 86(1):26-37. PubMed ID: 17595533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neurohormone systems.
    Bugajski J
    J Physiol Pharmacol; 1996 Dec; 47(4):559-75. PubMed ID: 9116324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L; Catania A; Baldini M; Orsatti A; Motta P; Peracchi G
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone.
    Payne LC; Weigent DA; Blalock JE
    Biochem Biophys Res Commun; 1994 Jan; 198(2):480-4. PubMed ID: 8297358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.
    Gwosdow AR; Kumar MS; Bode HH
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E65-70. PubMed ID: 2154118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
    Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
    Peterson ME; Kemppainen RJ; Orth DN
    Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin 1 beta: corticotropin releasing factor and ACTH release and gene expression in the male rat: in vivo and in vitro studies.
    Mélik Parsadaniantz S; Levin N; Lenoir V; Roberts JL; Kerdelhué B
    J Neurosci Res; 1994 Apr; 37(6):675-82. PubMed ID: 7519272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal glucocorticoids blunt the functioning of the hypothalamic-pituitary-adrenal axis of neonates and disturb some behaviors in juveniles.
    Burlet G; Fernette B; Blanchard S; Angel E; Tankosic P; Maccari S; Burlet A
    Neuroscience; 2005; 133(1):221-30. PubMed ID: 15893645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.